Last updated on December 2018

A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer


Brief description of study

The purpose of this study is to evaluate the efficacy and safety of prexasertib in women with platinum-resistant or refractory recurrent ovarian cancer.

Clinical Study Identifier: NCT03414047

Contact Investigators or Research Sites near you

Start Over

MICHAEL A. GOLD

Cancer Care Associates
Tulsa, OK United States
3.3miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.